Uses for WSX ligands in hematopoiesis are disclosed. In particular, in vitro and in vivo methods for stimulating hematopoiesis (e.g., myelopoiesis, erythropoiesis and especially, lymphopoiesis) using a WSX ligand (e.g., anti-WSX receptor agonist antibodies or OB protein), and optionally another cytokine, are described.

 
Web www.patentalert.com

< Compounds and compositions for delivering active agents

< Androgen regulated prostate specific nucleic acids

> Nucleic acids encoding BDP-1

> Amplification of denatured and stabilized nucleic acids

~ 00277